GTCR's Sterigenics Completes $826M Add-On of Nordion
August 08, 2014
Sterigenics, a GTCR portfolio company, has completed its $826 million acquisition of Nordion (NYSE: NDZ), a provider of health sciences products and services. As part of the deal, Nordion shareholders will receive $13 in cash in exchange for each common share held. The terms are higher than those announced in March, which involved a $727 million valuation and $11.75 per share. Nordion, which will continue to operate as a standalone business under the same, provides medical isotopes and sterilization technologies used by pharmaceutical and biotechnology companies. Sterigenics, a provider of outsourced contract sterilization services, announced the deal has created the only vertically integrated sterilization company in the world.